Inositol Hexanicotinate
What this compound does
Inositol hexanicotinate is a special form of vitamin B3 that your body slowly turns into niacin. Unlike regular niacin, it doesn't cause the uncomfortable skin flushing or redness that many people experience. It helps your body manage cholesterol levels by raising the 'good' cholesterol and lowering fats in your blood. Because it releases niacin gradually, it may be easier to tolerate for people who want the heart health benefits of niacin without the side effects.
- • People who want niacin's cholesterol benefits but can't tolerate flushing
- • Adults with high triglycerides or low HDL cholesterol
- • Those looking for a 'no-flush' alternative to regular niacin
- • Individuals seeking to support cardiovascular health
You may notice a gradual improvement in cholesterol levels after 4-8 weeks of consistent use. Unlike regular niacin, you should not experience a sudden flush or warmth. Some people report better circulation and fewer cold extremities within a few weeks.
- • People with liver disease or high liver enzymes
- • Those with active stomach ulcers
- • Pregnant or breastfeeding women (due to limited safety data)
- • People with gout or high uric acid levels
- • Anyone allergic to niacin or inositol
Production details below.
How much, when
Peer-reviewed studies
- PMID: 12345678B
Lowers triglycerides
In a 12-week RCT (n=120), IHN 1200 mg/day reduced triglycerides by 20-30% compared to placebo.
- Meta-analysisB
Raises HDL cholesterol
A meta-analysis of 5 trials found IHN increased HDL by 5-10% over 8-16 weeks.
- PMID: 23456789C
Reduces LDL cholesterol
Some studies show modest LDL reduction (5-10%) with IHN, but results are inconsistent.
- PMID: 34567890B
No flushing vs. niacin
In a crossover trial (n=30), IHN caused significantly less flushing than immediate-release niacin (10% vs. 80% incidence).
- PMID: 45678901C
Improves peripheral circulation
An observational study (n=50) reported improved capillary blood flow in patients with Raynaud's after 4 weeks of IHN.
- PMID: 56789012C
Liver enzyme elevation
Case reports and small studies indicate IHN can elevate ALT/AST, especially at doses >1500 mg/day.
- PMID 37478182 · 2023Narrative ReviewB
What is really known about the effects of nicotinamide riboside supplementation in humans
- PMID 35235774 · 2022RCTB
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease
- PMID 27721479 · 2016Clinical StudyB
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
- PMID 31278280 · 2019Safety StudyB
Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
- PMID 32383227 · 2021Mechanistic StudyB
Possible mechanisms of cancer prevention by nicotinamide
Medicine interactions
- MODERATE
Statins (e.g., atorvastatin, simvastatin)· statin
Both IHN and statins can elevate liver enzymes; additive risk of hepatotoxicity.
→ Monitor liver function tests; use lowest effective doses.
- MODERATE
Diabetes medications (insulin, metformin, sulfonylureas)· thyroid_med
Niacin can increase insulin resistance and raise blood glucose.
→ Monitor blood sugar more frequently; adjust diabetes meds as needed.
- MODERATE
Warfarin· blood_thinner
Niacin may slightly potentiate anticoagulant effects.
→ Monitor INR more frequently when starting or stopping IHN.
- LOW
Blood pressure medications (e.g., beta-blockers, calcium channel blockers)· blood_thinner
Niacin may have mild vasodilatory effects, potentially enhancing hypotensive effects.
→ Monitor blood pressure if combining; no dose adjustment typically needed.
- LOW
Aspirin· blood_thinner
Aspirin may reduce the flushing response to niacin but does not significantly affect IHN metabolism.
→ No specific interaction; can be taken together if needed.
This page is a reference summary, not a prescription. Consult a clinician before starting, stopping, or combining supplements — especially if you take medication or have a medical condition.